Washington Regional Home Health Location: 2683 N Quality Lane, Fayetteville, Arkansas 72703 Ratings: Phone: (479) 713-1840 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Encompass Health Home Health Location: 540 E Appleby Drive, Suite 102, Fayetteville, Arkansas 72703 Ratings: Phone: (479) 442-6363 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Encompass Health Home Health Location: 540 E Appleby Road, Suite 103, Fayetteville, Arkansas 72703 Ratings: Phone: (479) 636-2611 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Care Iv Home Health Location: 3801 Johnson Mill Blvd, Fayetteville, Arkansas 72704 Ratings: Phone: (479) 750-1155 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Home Health Aide |
News Archive
Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, and the Oxford Health NHS Foundation Trust today announced a joint study published in the Behavior Research and Therapy journal showing almost two-thirds of people seeking treatment for anxiety or depression and who had sleep difficulty saw their mental health improve substantially more by combining enrollment in Sleepio, Big Health's digital therapeutic for insomnia, with NHS Improving Access to Psychological Therapies programme care, when compared to IAPT care alone.
Mpex Pharmaceuticals, Inc. today announced positive data from its Phase 2b clinical trial with Aeroquin((R)) (a novel aerosol formulation of levofloxacin, MP-376) in cystic fibrosis (CF). Trial results showed that nebulized Aeroquin met the primary endpoint of reducing bacterial counts of Pseudomonas aeruginosa (P. aeruginosa) in sputum after 28 days of dosing versus placebo.
A research team, headed by Theodore Friedmann, MD, professor of pediatrics at the University of California, San Diego School of Medicine, says a gene mutation that causes a rare but devastating neurological disorder known as Lesch-Nyhan syndrome appears to offer clues to the developmental and neuronal defects found in other, diverse neurological disorders like Alzheimer's, Parkinson's and Huntington's diseases.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the acute coronary syndrome (ACS) drug market in China will grow from $326 million in 2010 to $448 million in 2015.
› Verified 4 days ago